Results 261 to 270 of about 175,178 (288)
Some of the next articles are maybe not open access.

Characterization of porcine CD19 and anti-CD19 monoclonal antibodies

Molecular Immunology, 2004
CD19 is an important pan B cell marker and co-stimulatory protein in humans and mice. Efforts to further characterize B cell ontogeny in swine have been hampered by the lack of monoclonal antibodies (mAb) to valuable surface markers like Vpre-B, CD19, CD34 and CD43.
Jishan, Sun   +4 more
openaire   +2 more sources

CD19, from bench to bedside

Immunology Letters, 2017
As a 95-kDa member of the immunoglobulin super-family expressed exclusively on B lymphocytes, CD19 is a critical co-receptor for B cell antigen receptor (BCR) signal transduction. Co-ligation of CD19 with the BCR synergistically enhances calcium release, mitogen-activated protein kinase activity and cell proliferation.
Xinchen, Li   +6 more
openaire   +2 more sources

Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins

Molecular Pharmaceutics, 2019
CD19-targeted chimeric antigen receptor (CAR) T-cells (CAR19s) show remarkable efficacy in the treatment of relapsed/refractory acute lymphocytic leukemia and Non-Hodgkin's lymphoma. However, the use of CAR T-cell therapy against CD19-negative hematological cancers and solid tumors has been challenging.
Justin R. Klesmith   +9 more
openaire   +2 more sources

CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19.

The Journal of Immunology, 1997
Abstract Establishing signal transduction thresholds that regulate B lymphocyte responses to foreign Ags and tolerance to self Ags is critical for humoral immune responses. The effects of altered signaling thresholds in B lymphocytes were examined in CD19-deficient mice and transgenic mice that expressed human CD19 at varying densities ...
S, Sato   +3 more
openaire   +2 more sources

Deficiencies in the CD19 complex

Clinical Immunology, 2018
Signaling via the CD19-complex, consisting of CD19, CD81, CD21 and CD225, is critically important for B-cell development, differentiation and maturation. In this complex, each protein has its own distinct function. Over the past decade, 15 patients with antibody deficiency due to deficiencies in the CD19-complex have been described. These patients have
Marjolein W.J. Wentink   +4 more
openaire   +5 more sources

CD34+CD19−, CD34+CD19+ and CD34−CD19+ Cells May All Have Leukemia-Initiating Potential in NOD/Scid Mice.

Blood, 2006
Abstract Current data on the leukemic stem cell (LSC) compartment in childhood acute lymphoblastic leukemia (ALL) are conflicting. The traditional hypothesis supposed that childhood ALL originates in a lymphoid progenitor cell and this is assumed to be consistent with the overall good treatment responses in pediatric patients.
Christoph Le Viseur   +8 more
openaire   +1 more source

CD19 Deficiency Due to Genetic Defects in the CD19 and CD81 Genes

2018
CD19 is a transmembrane protein specifically expressed on B cells and acts together with CD21, CD81, and CD225 to reduce the threshold for B-cell antigen receptor (BCR) signaling. To date, 11 patients with childhood-onset hypogammaglobulinemia have been identified with CD19 deficiency due to mutations in the CD19 or CD81 genes.
Menno C. van Zelm, Ismail Reisli
openaire   +1 more source

BAFF-driven autoimmunity requires CD19 expression

Journal of Autoimmunity, 2015
B cell activating factor of the tumor necrosis factor family (BAFF or BLyS) is a critical factor for B cell survival and maturation. BAFF-transgenic (BAFF-Tg) mice develop autoimmunity that resembles systemic lupus erythematosus (SLE) in a T cell-independent but MyD88-dependent manner, implicating toll-like receptor (TLR) signaling. The specific B cell
Kirsten A. Fairfax   +7 more
openaire   +2 more sources

CD19

AfCS-Nature Molecule Pages, 2006
Charlene Prazma   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy